Hence then, the article about keiferx expands exclusive licensing agreement with georgetown university to include multiple disease indications for portfolio of novel tyrosine kinase inhibitors was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( KeifeRx Expands Exclusive Licensing Agreement with Georgetown University to Include Multiple Disease Indications for Portfolio of Novel Tyrosine Kinase Inhibitors )
Last updated :
Also on site :
- North Korean operatives stole $2 billion last year—and financial firms are the next target
- Polestar CEO tells CNBC ‘pump anxiety’ has made EVs ‘all about money’
- License To Deliver: Some Midwives Break the Law To Assist With Home Births